Protocol 10522, Phase I Clinical Trial of CA-4948 in Combination with Gemcitabine and Nab-Paclitaxel in Metastatic on Unresectable Pancreatic Ductal Carcinoma
Details
Age
Adult
Type of Study
Treatment
Locations
CTRC Inpatient
University of Colorado Hospital
Principal Investigator
Robert Lentz, MD
Study ID
Protocol Number: 23-0613
More information available at ClinicalTrials.gov: NCT05685602
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers